QNRX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	55 054.00
Średni wolumen	619 185
Kapitalizacja rynkowa	629 353
EPS	$0 ( 2024-03-14 )
Następna data zysków	( $-2.31 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0700
ATR14	$0.00300 (0.47%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-26	Sember Michael T	Buy	7 652	Share Option (Right to Buy)
2023-10-26	Dunn Gordon	Buy	51 149	Share Option (Right to Buy)
2023-10-26	Myers Michael	Buy	80 965	Share Option (Right to Buy)
2023-10-26	Culverwell Anthony James	Buy	7 652	Share Option (Right to Buy)
2023-10-26	Cooper Joseph Patrick	Buy	7 652	Share Option (Right to Buy)

INSIDER POWER
-99.96
Last 24 transactions
Buy: 251 340 \| Sell: 1 792 856 400

Wolumen Korelacja

Długi: -0.08 (neutral)

Krótki: 0.63 (weak)

Signal:(66.877) Neutral

Quoin Pharmaceuticals, Korelacja

10 Najbardziej pozytywne korelacje
BOKF	0.887
CARE	0.879
FSBC	0.872
COLB	0.87
FFIC	0.867
BIRD	0.866
CCNE	0.863
ABCB	0.863
FRST	0.862
BCOW	0.86

10 Najbardziej negatywne korelacje
BNIXU	-0.903
PBAXU	-0.874
BLPH	-0.87
TRMD	-0.861
SVFC	-0.836
CALT	-0.806
ELEV	-0.805

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Quoin Pharmaceuticals, Korelacja - Waluta/Towar

-0.20
( neutral )

0.04
( neutral )

0.00
( neutral )

0.23
( neutral )

Quoin Pharmaceuticals, Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-103 438 (0.00 %)
EPS:	$-9.62

FY	2023
Przychody:	$0
Zysk brutto:	$-103 438 (0.00 %)
EPS:	$-9.62

FY	2022
Przychody:	$0
Zysk brutto:	$-103 635 (0.00 %)
EPS:	$-22.97

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-30.71

Financial Reports:

No articles found.

Quoin Pharmaceuticals,

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.